Simplex Trading
ENTA icon

Simplex Trading’s Enanta Pharmaceuticals ENTA Stock Holding History

Simplex Trading’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Hold
100
– – ﹤0.01% 8521
2025
Q4 		$1.58K Sell
100
-15,100
-99% -$192K ﹤0.01% 7911
2025
Q3 		$181K Buy
15,200
+13,900
+1,069% +$111K ﹤0.01% 5058
2025
Q2 		$9K Buy
1,300
+900
+225% +$5.41K ﹤0.01% 7372
2025
Q1 		$2K Buy
+400
New +$2.47K ﹤0.01% 7972
2024
Q4 		– Sell
-400
Closed -$4K – 8776
2024
Q3 		$4K Hold
400
– – ﹤0.01% 7704
2024
Q2 		$5K Buy
+400
New +$5.4K ﹤0.01% 7853
2023
Q2 		– Sell
-400
Closed -$16K – 9204
2023
Q1 		$16K Sell
400
-3,400
-89% -$162K ﹤0.01% 7126
2022
Q4 		$176K Sell
3,800
-10,200
-73% -$465K ﹤0.01% 4376
2022
Q3 		$726K Sell
14,000
-700
-5% -$40.9K ﹤0.01% 3031
2022
Q2 		$694K Buy
14,700
+13,400
+1,031% +$727K ﹤0.01% 3047
2022
Q1 		$92K Buy
1,300
+1,000
+333% +$65.1K ﹤0.01% 6270
2021
Q4 		$22K Buy
300
+200
+200% +$15.7K ﹤0.01% 8249
2021
Q3 		$4K Hold
100
– – ﹤0.01% 9337
2021
Q2 		$4K Buy
100
+98
+4,900% +$4.8K ﹤0.01% 9518
2021
Q1 		$9K Sell
2
-12
-86% -$599 ﹤0.01% 7942
2020
Q4 		$58K Buy
14
+13
+1,300% +$572 ﹤0.01% 6021
2020
Q3 		$4K Sell
1
-6
-86% -$291 ﹤0.01% 7187
2020
Q2 		$35K Buy
7
+4
+133% +$207 ﹤0.01% 5797
2020
Q1 		$15K Sell
3
-313
-99% -$16.7K ﹤0.01% 6171
2019
Q4 		$1.95M Buy
316
+295
+1,405% +$18.3K ﹤0.01% 1499
2019
Q3 		$126K Buy
21
+20
+2,000% +$1.49K ﹤0.01% 4067
2019
Q2 		$8K Sell
1
-20
-95% -$1.8K ﹤0.01% 6219
2019
Q1 		$200K Sell
21
-4
-16% -$359 ﹤0.01% 3610
2018
Q4 		$177K Buy
25
+21
+525% +$1.61K ﹤0.01% 3277
2018
Q3 		$34K Sell
4
-9
-69% -$902 ﹤0.01% 5523
2018
Q2 		$150K Sell
13
-23
-64% -$2.29K ﹤0.01% 3812
2018
Q1 		$14K Buy
36
+31
+620% +$2.39K ﹤0.01% 3686
2017
Q4 		$7K Sell
5
-15
-75% -$751 ﹤0.01% 4182
2017
Q3 		$14K Sell
20
-67
-77% -$2.69K ﹤0.01% 3472
2017
Q2 		$22K Buy
87
+47
+118% +$1.5K ﹤0.01% 3209
2017
Q1 		$5K Buy
40
+32
+400% +$997 ﹤0.01% 4563
2016
Q4 		$4K Buy
+8
New +$229 ﹤0.01% 4512
2016
Q3 		– Sell
-46
Closed -$2K – 5938
2016
Q2 		$2K Buy
46
+15
+48% +$393 ﹤0.01% 4906
2016
Q1 		$2K Buy
31
+9
+41% +$251 ﹤0.01% 4698
2015
Q4 		$2K Buy
+22
New +$717 ﹤0.01% 4477
2015
Q3 		– Sell
-11
Closed -$10K – 5653
2015
Q2 		$10K Buy
11
+3
+38% +$117 ﹤0.01% 3048
2015
Q1 		$1K Buy
8
+6
+300% +$233 ﹤0.01% 4450
2014
Q4 		$3K Buy
+2
New +$90 ﹤0.01% 3448

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Simplex Trading's ENTA Position: Q1 2026 in Review

Simplex Trading reduced its Enanta Pharmaceuticals (ENTA) stake by 51% in Q1 2026, selling an estimated $6.26K and leaving 455 shares worth $5.75K. The position accounts for ﹤0.01% of the portfolio, ranked #7791.

Simplex Trading first reported a position in ENTA in Q4 2014 and has held it in 26 quarters since. The position peaked at $508K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Simplex Trading held 455 shares of Enanta Pharmaceuticals worth $5.75K as of Q1 2026.
  • Simplex Trading sold 467 Enanta Pharmaceuticals shares in Q1 2026, an estimated $6.26K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7791 holding.
  • Simplex Trading first reported a position in Enanta Pharmaceuticals in Q4 2014 and has held it in 26 quarters since.
  • Simplex Trading's Enanta Pharmaceuticals position peaked at $508K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.